1. Evaluates skin irritation/sensitization from turmeric/EGCG emulgel.
2. Randomized double-blind study with 60 healthy participants.
3. Uses Draize scoring for irritation assessment.
4. Employs validated patch testing protocol.
5. Study limited to Fitzpatrick skin types III and IV.
6. Results pending; will inform larger trials for inflammatory diseases.
7. Researchers from Chiang Mai University and no conflicts of interest reported.

Source: BMJ Open